TY - JOUR
T1 - Chlorhexidine sustained-release varnishes for catheter coating – Dissolution kinetics and antibiofilm properties
AU - Gefter (Shenderovich), Julia
AU - Zaks, Batya
AU - Kirmayer, David
AU - Lavy, Eran
AU - Steinberg, Doron
AU - Friedman, Michael
N1 - Publisher Copyright:
© 2017
PY - 2018/1/15
Y1 - 2018/1/15
N2 - Catheter-associated urinary tract infections are difficult to eradicate or prevent, due to their biofilm-related nature. Chlorhexidine, a widely used antiseptic, was previously found to be effective against catheter-related biofilms. For the present study, we developed sustained-release chlorhexidine varnishes for catheter coating and evaluated their antibiofilm properties and chlorhexidine-dissolution kinetics under various conditions. The varnishes were based on ethylcellulose or ammonio methacrylate copolymer type A (Eudragit® RL). Chlorhexidine was released by diffusion from a heterogeneous matrix in the case of the ethylcellulose-based formulation, and from a homogeneous matrix in the case of Eudragit® RL. This dictated the release pattern of chlorhexidine under testing conditions: from film specimens, and from coated catheters in a static or flow-through system. Momentary saturation was observed with the flow-through system in Eudragit® RL-based coatings, an effect that might be present in vivo with other formulations as well. The coatings were retained on the catheters for at least 2 weeks, and showed prolonged activity in a biological medium, including an antibiofilm effect against Pseudomonas aeruginosa. The current study demonstrates the potential of catheter coatings with sustained release of chlorhexidine in the prevention of catheter-associated urinary tract infections.
AB - Catheter-associated urinary tract infections are difficult to eradicate or prevent, due to their biofilm-related nature. Chlorhexidine, a widely used antiseptic, was previously found to be effective against catheter-related biofilms. For the present study, we developed sustained-release chlorhexidine varnishes for catheter coating and evaluated their antibiofilm properties and chlorhexidine-dissolution kinetics under various conditions. The varnishes were based on ethylcellulose or ammonio methacrylate copolymer type A (Eudragit® RL). Chlorhexidine was released by diffusion from a heterogeneous matrix in the case of the ethylcellulose-based formulation, and from a homogeneous matrix in the case of Eudragit® RL. This dictated the release pattern of chlorhexidine under testing conditions: from film specimens, and from coated catheters in a static or flow-through system. Momentary saturation was observed with the flow-through system in Eudragit® RL-based coatings, an effect that might be present in vivo with other formulations as well. The coatings were retained on the catheters for at least 2 weeks, and showed prolonged activity in a biological medium, including an antibiofilm effect against Pseudomonas aeruginosa. The current study demonstrates the potential of catheter coatings with sustained release of chlorhexidine in the prevention of catheter-associated urinary tract infections.
KW - Antibiofilm
KW - Catheter-associated infection
KW - Chlorhexidine
KW - Dissolution testing
KW - Sustained release
KW - Varnish
UR - http://www.scopus.com/inward/record.url?scp=85032912668&partnerID=8YFLogxK
U2 - 10.1016/j.ejps.2017.10.041
DO - 10.1016/j.ejps.2017.10.041
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 29104066
AN - SCOPUS:85032912668
SN - 0928-0987
VL - 112
SP - 1
EP - 7
JO - European Journal of Pharmaceutical Sciences
JF - European Journal of Pharmaceutical Sciences
ER -